KEGG   PATHWAY: hai05206
Entry
hai05206                    Pathway                                
Name
MicroRNAs in cancer - Hipposideros armiger (great roundleaf bat)
Description
MicroRNA (miRNA) is a cluster of small non-encoding RNA molecules of 21 - 23 nucleotides in length, which controls gene expression post-transcriptionally either via the degradation of target mRNAs or the inhibition of protein translation. Using high-throughput profiling, dysregulation of miRNAs has been widely observed in different stages of cancer. The upregulation (overexpression) of specific miRNAs could lead to the repression of tumor suppressor gene expression, and conversely the downregulation of specific miRNAs could result in an increase of oncogene expression; both these situations induce subsequent malignant effects on cell proliferation, differentiation, and apoptosis that lead to tumor growth and progress. The miRNA signatures of cancer observed in various studies differ significantly. These inconsistencies occur due to the differences in the study populations and methodologies used. This pathway map shows the summarized results from various studies in 9 cancers, each of which is presented in a review article.
Class
Human Diseases; Cancer: overview
Pathway map
hai05206  MicroRNAs in cancer
hai05206

Organism
Hipposideros armiger (great roundleaf bat) [GN:hai]
Gene
109387530  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
109383166  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
109382836  TIMP3; metalloproteinase inhibitor 3 [KO:K16866]
109389264  KRAS; GTPase KRas isoform X1 [KO:K07827]
109373596  CDK6; cyclin-dependent kinase 6 isoform X1 [KO:K02091] [EC:2.7.11.22]
109375294  CDC25A; M-phase inducer phosphatase 1 isoform X1 [KO:K06645] [EC:3.1.3.48]
109383851  CDC25B; LOW QUALITY PROTEIN: M-phase inducer phosphatase 2 [KO:K05866] [EC:3.1.3.48]
109392993  CDC25C; M-phase inducer phosphatase 3 isoform X1 [KO:K05867] [EC:3.1.3.48]
109381670  HMGA2; high mobility group protein HMGI-C [KO:K09283]
109389297  CCND1; G1/S-specific cyclin-D1 isoform X1 [KO:K04503]
109392488  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
109383495  CCNE1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
109376215  CCNE2; G1/S-specific cyclin-E2 [KO:K06626]
109386906  CRK; adapter molecule crk isoform X1 [KO:K04438]
109376239  CRKL; crk-like protein [KO:K04438]
109374070  HDAC4; histone deacetylase 4 [KO:K11406] [EC:3.5.1.98]
109394999  HDAC5; histone deacetylase 5 isoform X1 [KO:K11406] [EC:3.5.1.98]
109387440  FOXP1; forkhead box protein P1 isoform X1 [KO:K23582]
109395959  PIM1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
109389346  MET; hepatocyte growth factor receptor [KO:K05099] [EC:2.7.10.1]
109384340  DNMT3A; DNA (cytosine-5)-methyltransferase 3A isoform X1 [KO:K17398] [EC:2.1.1.37]
109384467  DNMT3B; DNA (cytosine-5)-methyltransferase 3B isoform X1 [KO:K17399] [EC:2.1.1.37]
109372291  MCL1; induced myeloid leukemia cell differentiation protein Mcl-1 [KO:K02539]
109393645  BCL2L2; bcl-2-like protein 2 [KO:K02163]
109388365  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
109382864  VEGFA; vascular endothelial growth factor A [KO:K05448]
109392909  ZEB1; zinc finger E-box-binding homeobox 1 isoform X1 [KO:K09299]
109381205  TGFB2; transforming growth factor beta-2 isoform X1 [KO:K13376]
109375388  EZR; ezrin isoform X1 [KO:K08007]
109384890  PDCD4; programmed cell death protein 4 isoform X1 [KO:K16865]
109392135  CREBBP; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
109392262  EP300; histone acetyltransferase p300 isoform X1 [KO:K04498] [EC:2.3.1.48]
109387094  TPM1; tropomyosin alpha-1 chain isoform X1 [KO:K10373]
109393176  SPRY2; protein sprouty homolog 2 [KO:K17383]
109390784  BCL2; apoptosis regulator Bcl-2 isoform X1 [KO:K02161]
109390771  SERPINB5; serpin B5 [KO:K10139]
109392376  ST14; suppressor of tumorigenicity 14 protein [KO:K08670] [EC:3.4.21.109]
109385488  cytochrome P450 1B1 [KO:K07410] [EC:1.14.14.1]
109381262  MTOR; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
109393012  RPTOR; regulatory-associated protein of mTOR [KO:K07204]
109381840  1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial [KO:K07436] [EC:1.14.15.16]
109380800  ERBB2; receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
109396911  ERBB3; receptor tyrosine-protein kinase erbB-3 isoform X1 [KO:K05084] [EC:2.7.10.1]
109380669  ABL1; tyrosine-protein kinase ABL1 isoform X1 [KO:K06619] [EC:2.7.10.2]
109396252  TP63; tumor protein 63 [KO:K10149]
109393860  ZEB2; zinc finger E-box-binding homeobox 2 isoform X1 [KO:K23560]
109380204  FSCN1; fascin [KO:K23551]
109375870  RASSF1; ras association domain-containing protein 1 isoform X1 [KO:K09850]
109375495  HOXD10; homeobox protein Hox-D10 isoform X1 [KO:K09295]
109371588  DDIT4; DNA damage-inducible transcript 4 protein [KO:K08270]
109384070  BMF; bcl-2-modifying factor isoform X1 [KO:K17460]
109395380  PAK4; serine/threonine-protein kinase PAK 4 isoform X1 [KO:K05734] [EC:2.7.11.1]
109379910  MMP9; matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
109395396  SLC7A1; high affinity cationic amino acid transporter 1 [KO:K13863]
109375541  CCNG1; cyclin-G1 [KO:K10145]
109377639  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
109386780  STMN1; stathmin [KO:K04381]
109395763  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
109383211  MYC; myc proto-oncogene protein [KO:K04377]
109395706  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
109375639  HRAS; GTPase HRas isoform X1 [KO:K02833]
109385150  GTPase HRas-like [KO:K02833]
109377015  NRAS; GTPase NRas [KO:K07828]
109391637  DNMT1; DNA (cytosine-5)-methyltransferase 1 isoform X1 [KO:K00558] [EC:2.1.1.37]
109390647  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
109391522  APC; adenomatous polyposis coli protein [KO:K02085]
109396328  IRS1; insulin receptor substrate 1 [KO:K16172]
109382484  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
109395865  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
109373811  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
109377280  MAPK7; mitogen-activated protein kinase 7 isoform X1 [KO:K04464] [EC:2.7.11.24]
109381238  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
109394108  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
109372681  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
109372836  LOW QUALITY PROTEIN: heterogeneous nuclear ribonucleoprotein K-like [KO:K12886]
109374626  HNRNPK; heterogeneous nuclear ribonucleoprotein K isoform X1 [KO:K12886]
109393785  RECK; reversion-inducing cysteine-rich protein with Kazal motifs [KO:K17461]
109381623  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
109383948  IRS2; LOW QUALITY PROTEIN: insulin receptor substrate 2 [KO:K07187]
109381350  NOTCH1; neurogenic locus notch homolog protein 1 [KO:K02599]
109389880  NOTCH2; neurogenic locus notch homolog protein 2 [KO:K20994]
109376063  NOTCH3; neurogenic locus notch homolog protein 3 [KO:K20995]
109373115  NOTCH4; neurogenic locus notch homolog protein 4 [KO:K20996]
109394756  BMI1; polycomb complex protein BMI-1 [KO:K11459]
109387587  MMP16; matrix metalloproteinase-16 isoform X1 [KO:K07996] [EC:3.4.24.-]
109371552  ATM; serine-protein kinase ATM isoform X1 [KO:K04728] [EC:2.7.11.1]
109387185  SOCS1; suppressor of cytokine signaling 1 [KO:K04694]
109381148  CD44; CD44 antigen isoform X1 [KO:K06256]
109382752  DICER1; endoribonuclease Dicer isoform X1 [KO:K11592] [EC:3.1.26.-]
109379491  FZD3; frizzled-3 isoform X1 [KO:K02329]
109391860  ITGA5; integrin alpha-5 [KO:K06484]
109388703  RDX; radixin isoform X1 [KO:K05762]
109376114  RHOA; transforming protein RhoA isoform X1 [KO:K04513]
109371644  PLAU; urokinase-type plasminogen activator [KO:K01348] [EC:3.4.21.73]
109392454  BAK1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
109394147  ZFPM2; zinc finger protein ZFPM2 [KO:K17442]
109380323  ITGB3; integrin beta-3 [KO:K06493]
109385966  UBE2I; SUMO-conjugating enzyme UBC9 [KO:K10577]
109381628  SOX4; transcription factor SOX-4 [KO:K23581]
109385116  TNN; tenascin-N [KO:K06252]
109385122  TNR; tenascin-R [KO:K06252]
109373091  TNXB; LOW QUALITY PROTEIN: tenascin-X [KO:K06252]
109390423  TNC; tenascin isoform X1 [KO:K06252]
109371291  ABCB1; multidrug resistance protein 1 [KO:K05658] [EC:7.6.2.2]
109395236  ABCC1; multidrug resistance-associated protein 1 [KO:K05665] [EC:7.6.2.3]
109395752  BRCA1; breast cancer type 1 susceptibility protein [KO:K10605] [EC:2.3.2.27]
109395991  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
109393452  EFNA4; ephrin-A4 isoform X1 [KO:K05462]
109388439  EFNA5; ephrin-A5 isoform X1 [KO:K05462]
109390629  EFNA2; ephrin-A2 [KO:K05462]
109393359  EFNA1; ephrin-A1 [KO:K05462]
109393364  EFNA3; ephrin-A3 isoform X1 [KO:K05462]
109384080  THBS1; thrombospondin-1 [KO:K16857]
109380727  IGF2BP1; insulin-like growth factor 2 mRNA-binding protein 1 isoform X1 [KO:K17391]
109375367  TRIM71; E3 ubiquitin-protein ligase TRIM71 [KO:K12035] [EC:2.3.2.27]
109372541  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
109386279  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
109379092  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
109385803  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
109394900  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
109380289  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
109386578  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
109372505  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
109383688  GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364]
109390958  FGFR3; fibroblast growth factor receptor 3 isoform X1 [KO:K05094] [EC:2.7.10.1]
109382677  RPS6KA5; ribosomal protein S6 kinase alpha-5 isoform X1 [KO:K04445] [EC:2.7.11.1]
109394672  TP53; cellular tumor antigen p53 isoform X1 [KO:K04451]
109381699  MDM2; E3 ubiquitin-protein ligase Mdm2 [KO:K06643] [EC:2.3.2.27]
109386503  MDM4; protein Mdm4 isoform X1 [KO:K10127]
109381815  PDGFRA; platelet-derived growth factor receptor alpha isoform X1 [KO:K04363] [EC:2.7.10.1]
109379925  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
109378365  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
109384548  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
109385252  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
109388626  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
109385471  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
109375221  SOS2; son of sevenless homolog 2 [KO:K03099]
109393422  SHC1; SHC-transforming protein 1 isoform X1 [KO:K06279]
109380137  PDGFA; platelet-derived growth factor subunit A [KO:K04359]
109394486  SHC4; SHC-transforming protein 4 isoform X1 [KO:K17449]
109392273  PDGFB; platelet-derived growth factor subunit B isoform X1 [KO:K17386]
109375002  PDGFRB; platelet-derived growth factor receptor beta isoform X1 [KO:K05089] [EC:2.7.10.1]
109374675  cyclin-dependent kinase inhibitor 2A-like isoform X1 [KO:K06621]
109377242  E2F1; transcription factor E2F1 [KO:K17454]
109386699  E2F2; transcription factor E2F2 isoform X1 [KO:K09389]
109393533  BCL2L11; bcl-2-like protein 11 isoform X1 [KO:K16341]
109384766  MARCKS; myristoylated alanine-rich C-kinase substrate [KO:K12561]
109379244  BMPR2; bone morphogenetic protein receptor type-2 [KO:K04671] [EC:2.7.11.30]
109391669  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
109384760  HDAC2; histone deacetylase 2 isoform X1 [KO:K06067] [EC:3.5.1.98]
109395452  EZH2; histone-lysine N-methyltransferase EZH2 isoform X1 [KO:K11430] [EC:2.1.1.356]
109396845  GLS2; glutaminase liver isoform, mitochondrial [KO:K01425] [EC:3.5.1.2]
109393280  GLS; glutaminase kidney isoform, mitochondrial isoform X1 [KO:K01425] [EC:3.5.1.2]
109371987  SIRT1; NAD-dependent protein deacetylase sirtuin-1 [KO:K11411] [EC:2.3.1.286]
109380253  WNT3; proto-oncogene Wnt-3 isoform X1 [KO:K00312]
109377253  WNT3A; protein Wnt-3a [KO:K00312]
109384316  CDCA5; sororin isoform X1 [KO:K17390]
109385262  KIF23; kinesin-like protein KIF23 isoform X1 [KO:K17387]
109388840  ROCK1; rho-associated protein kinase 1 isoform X1 [KO:K04514] [EC:2.7.11.1]
109393868  PRKCE; protein kinase C epsilon type [KO:K18050] [EC:2.7.11.13]
109386509  SLC45A3; solute carrier family 45 member 3 [KO:K15379]
109393566  VIM; vimentin [KO:K07606]
Reference
  Authors
Lee YS, Dutta A
  Title
MicroRNAs in cancer.
  Journal
Annu Rev Pathol 4:199-227 (2009)
DOI:10.1146/annurev.pathol.4.110807.092222
Reference
  Authors
Babashah S, Soleimani M
  Title
The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.
  Journal
Eur J Cancer 47:1127-37 (2011)
DOI:10.1016/j.ejca.2011.02.008
Reference
  Authors
Garzon R, Calin GA, Croce CM
  Title
MicroRNAs in Cancer.
  Journal
Annu Rev Med 60:167-79 (2009)
DOI:10.1146/annurev.med.59.053006.104707
Reference
  Authors
Chen PS, Su JL, Hung MC
  Title
Dysregulation of microRNAs in cancer.
  Journal
J Biomed Sci 19:90 (2012)
DOI:10.1186/1423-0127-19-90
Reference
  Authors
Ling H, Zhang W, Calin GA
  Title
Principles of microRNA involvement in human cancers.
  Journal
Chin J Cancer 30:739-48 (2011)
DOI:10.5732/cjc.011.10243
Reference
  Authors
Iorio MV, Croce CM
  Title
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.
  Journal
EMBO Mol Med 4:143-59 (2012)
DOI:10.1002/emmm.201100209
Reference
  Authors
Sayed D, Abdellatif M
  Title
MicroRNAs in development and disease.
  Journal
Physiol Rev 91:827-87 (2011)
DOI:10.1152/physrev.00006.2010
Reference
  Authors
Wang Q, Wang S, Wang H, Li P, Ma Z
  Title
MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.
  Journal
Exp Biol Med (Maywood) 237:227-35 (2012)
DOI:10.1258/ebm.2011.011192
Reference
  Authors
Song JH, Meltzer SJ
  Title
MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers.
  Journal
Gastroenterology 143:35-47.e2 (2012)
DOI:10.1053/j.gastro.2012.05.003
Reference
  Authors
Chu Y, Zhu H, Lv L, Zhou Y, Huo J
  Title
MiRNA s in oesophageal squamous cancer.
  Journal
Neth J Med 71:69-75 (2013)
Reference
  Authors
Kan T, Meltzer SJ
  Title
MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
  Journal
Curr Opin Pharmacol 9:727-32 (2009)
DOI:10.1016/j.coph.2009.08.009
Reference
  Authors
Smith CM, Watson DI, Michael MZ, Hussey DJ
  Title
MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
  Journal
World J Gastroenterol 16:531-7 (2010)
DOI:10.3748/wjg.v16.i5.531
Reference
  Authors
Song S, Ajani JA
  Title
The role of microRNAs in cancers of the upper gastrointestinal tract.
  Journal
Nat Rev Gastroenterol Hepatol 10:109-18 (2013)
DOI:10.1038/nrgastro.2012.210
Reference
  Authors
Liu WH, Yeh SH, Chen PJ
  Title
Role of microRNAs in hepatitis B virus replication and pathogenesis.
  Journal
Biochim Biophys Acta 1809:678-85 (2011)
DOI:10.1016/j.bbagrm.2011.04.008
Reference
  Authors
Hrasovec S, Glavac D
  Title
MicroRNAs as Novel Biomarkers in Colorectal Cancer.
  Journal
Front Genet 3:180 (2012)
DOI:10.3389/fgene.2012.00180
Reference
  Authors
Liu H
  Title
MicroRNAs in breast cancer initiation and progression.
  Journal
Cell Mol Life Sci 69:3587-99 (2012)
DOI:10.1007/s00018-012-1128-9
Reference
  Authors
Li SD, Zhang JR, Wang YQ, Wan XP
  Title
The role of microRNAs in ovarian cancer initiation and progression.
  Journal
J Cell Mol Med 14:2240-9 (2010)
DOI:10.1111/j.1582-4934.2010.01058.x
Reference
  Authors
Zabolotneva AA, Zhavoronkov A, Garazha AV, Roumiantsev SA, Buzdin AA
  Title
Characteristic patterns of microRNA expression in human bladder cancer.
  Journal
Front Genet 3:310 (2012)
DOI:10.3389/fgene.2012.00310
Reference
  Authors
Saini S, Majid S, Dahiya R
  Title
Diet, microRNAs and prostate cancer.
  Journal
Pharm Res 27:1014-26 (2010)
DOI:10.1007/s11095-010-0086-x
Related
pathway
hai05210  Colorectal cancer
hai05214  Glioma
hai05215  Prostate cancer
hai05219  Bladder cancer
hai05222  Small cell lung cancer
hai05223  Non-small cell lung cancer
KO pathway
ko05206   
LinkDB

DBGET integrated database retrieval system